Deep Track Capital, LP 13D and 13G filings for Albireo Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 08:33 am Sale |
2023-12-31 | 13G | Albireo Pharma, Inc. ALBO |
Deep Track Capital, LP | 0 0.000% |
-1,704,000 (Position Closed) |
Filing |
| 2023-02-14 08:23 am Purchase |
2022-12-31 | 13G | Albireo Pharma, Inc. ALBO |
Deep Track Capital, LP | 1,704,000 8.230% |
579,579 (+51.54%) |
Filing |
| 2022-10-03 4:37 pm Purchase |
2022-09-23 | 13G | Albireo Pharma, Inc. ALBO |
Deep Track Capital, LP | 1,124,421 5.460% |
1,124,421 (New Position) |
Filing |